nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromazepam—CYP1A2—Carmustine—lymphatic system cancer	0.179	0.273	CbGbCtD
Bromazepam—CYP2E1—Mitoxantrone—lymphatic system cancer	0.146	0.222	CbGbCtD
Bromazepam—CYP2C19—Teniposide—lymphatic system cancer	0.131	0.199	CbGbCtD
Bromazepam—CYP3A4—Cytarabine—lymphatic system cancer	0.0642	0.0975	CbGbCtD
Bromazepam—CYP3A4—Teniposide—lymphatic system cancer	0.0632	0.096	CbGbCtD
Bromazepam—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0442	0.0672	CbGbCtD
Bromazepam—CYP3A4—Vincristine—lymphatic system cancer	0.0304	0.0462	CbGbCtD
Bromazepam—Digestion impaired—Fludarabine—lymphatic system cancer	0.0105	0.0308	CcSEcCtD
Bromazepam—Haemoglobin decreased—Fludarabine—lymphatic system cancer	0.0102	0.0299	CcSEcCtD
Bromazepam—White blood cell count decreased—Mitoxantrone—lymphatic system cancer	0.00842	0.0246	CcSEcCtD
Bromazepam—Haemoglobin decreased—Mitoxantrone—lymphatic system cancer	0.00609	0.0178	CcSEcCtD
Bromazepam—Sleep disorder—Fludarabine—lymphatic system cancer	0.0059	0.0173	CcSEcCtD
Bromazepam—Aggression—Bleomycin—lymphatic system cancer	0.00587	0.0172	CcSEcCtD
Bromazepam—Speech disorder—Carmustine—lymphatic system cancer	0.00524	0.0153	CcSEcCtD
Bromazepam—Cardiac failure—Fludarabine—lymphatic system cancer	0.00524	0.0153	CcSEcCtD
Bromazepam—Depressed level of consciousness—Carmustine—lymphatic system cancer	0.00435	0.0127	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—lymphatic system cancer	0.00402	0.0117	CcSEcCtD
Bromazepam—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.00388	0.0113	CcSEcCtD
Bromazepam—Skin disorder—Mechlorethamine—lymphatic system cancer	0.00376	0.011	CcSEcCtD
Bromazepam—Anorexia—Mechlorethamine—lymphatic system cancer	0.00369	0.0108	CcSEcCtD
Bromazepam—Multiple fractures—Methotrexate—lymphatic system cancer	0.00359	0.0105	CcSEcCtD
Bromazepam—Fracture—Methotrexate—lymphatic system cancer	0.00359	0.0105	CcSEcCtD
Bromazepam—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00337	0.00985	CcSEcCtD
Bromazepam—Diplopia—Carmustine—lymphatic system cancer	0.00327	0.00956	CcSEcCtD
Bromazepam—Agitation—Teniposide—lymphatic system cancer	0.00322	0.00941	CcSEcCtD
Bromazepam—Cardiac failure—Mitoxantrone—lymphatic system cancer	0.00311	0.00911	CcSEcCtD
Bromazepam—Malnutrition—Fludarabine—lymphatic system cancer	0.00308	0.009	CcSEcCtD
Bromazepam—Ataxia—Carmustine—lymphatic system cancer	0.00307	0.00899	CcSEcCtD
Bromazepam—Cardiac arrest—Vincristine—lymphatic system cancer	0.00297	0.00868	CcSEcCtD
Bromazepam—Ataxia—Vincristine—lymphatic system cancer	0.00294	0.00858	CcSEcCtD
Bromazepam—Muscular weakness—Carmustine—lymphatic system cancer	0.00288	0.00843	CcSEcCtD
Bromazepam—Confusional state—Teniposide—lymphatic system cancer	0.00288	0.00843	CcSEcCtD
Bromazepam—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00286	0.00835	CcSEcCtD
Bromazepam—Agitation—Fludarabine—lymphatic system cancer	0.00283	0.00827	CcSEcCtD
Bromazepam—Tachycardia—Teniposide—lymphatic system cancer	0.00279	0.00816	CcSEcCtD
Bromazepam—Muscular weakness—Vincristine—lymphatic system cancer	0.00275	0.00805	CcSEcCtD
Bromazepam—Pruritus—Mechlorethamine—lymphatic system cancer	0.00274	0.00802	CcSEcCtD
Bromazepam—Anorexia—Teniposide—lymphatic system cancer	0.00272	0.00796	CcSEcCtD
Bromazepam—Hypotension—Teniposide—lymphatic system cancer	0.00267	0.00781	CcSEcCtD
Bromazepam—Convulsion—Fludarabine—lymphatic system cancer	0.00267	0.0078	CcSEcCtD
Bromazepam—Confusional state—Fludarabine—lymphatic system cancer	0.00253	0.0074	CcSEcCtD
Bromazepam—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00251	0.00734	CcSEcCtD
Bromazepam—Decreased appetite—Teniposide—lymphatic system cancer	0.00248	0.00726	CcSEcCtD
Bromazepam—Vomiting—Mechlorethamine—lymphatic system cancer	0.00246	0.00721	CcSEcCtD
Bromazepam—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00246	0.0072	CcSEcCtD
Bromazepam—Rash—Mechlorethamine—lymphatic system cancer	0.00244	0.00715	CcSEcCtD
Bromazepam—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00244	0.00714	CcSEcCtD
Bromazepam—Speech disorder—Methotrexate—lymphatic system cancer	0.00243	0.00709	CcSEcCtD
Bromazepam—Anorexia—Fludarabine—lymphatic system cancer	0.00239	0.007	CcSEcCtD
Bromazepam—Feeling abnormal—Teniposide—lymphatic system cancer	0.00235	0.00689	CcSEcCtD
Bromazepam—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00234	0.00685	CcSEcCtD
Bromazepam—Nausea—Mechlorethamine—lymphatic system cancer	0.0023	0.00673	CcSEcCtD
Bromazepam—Hallucination—Carmustine—lymphatic system cancer	0.00225	0.00658	CcSEcCtD
Bromazepam—Connective tissue disorder—Carmustine—lymphatic system cancer	0.00222	0.0065	CcSEcCtD
Bromazepam—Dyspepsia—Fludarabine—lymphatic system cancer	0.00221	0.00646	CcSEcCtD
Bromazepam—Decreased appetite—Fludarabine—lymphatic system cancer	0.00218	0.00638	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00217	0.00634	CcSEcCtD
Bromazepam—Fatigue—Fludarabine—lymphatic system cancer	0.00217	0.00633	CcSEcCtD
Bromazepam—Hallucination—Vincristine—lymphatic system cancer	0.00215	0.00628	CcSEcCtD
Bromazepam—Connective tissue disorder—Vincristine—lymphatic system cancer	0.00212	0.00621	CcSEcCtD
Bromazepam—Eye disorder—Carmustine—lymphatic system cancer	0.00211	0.00618	CcSEcCtD
Bromazepam—Hypersensitivity—Teniposide—lymphatic system cancer	0.00211	0.00616	CcSEcCtD
Bromazepam—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00207	0.00605	CcSEcCtD
Bromazepam—Asthenia—Teniposide—lymphatic system cancer	0.00205	0.006	CcSEcCtD
Bromazepam—Pruritus—Teniposide—lymphatic system cancer	0.00202	0.00591	CcSEcCtD
Bromazepam—Depressed level of consciousness—Methotrexate—lymphatic system cancer	0.00201	0.00589	CcSEcCtD
Bromazepam—Cardiac disorder—Vincristine—lymphatic system cancer	0.002	0.00586	CcSEcCtD
Bromazepam—Mental disorder—Carmustine—lymphatic system cancer	0.00198	0.0058	CcSEcCtD
Bromazepam—Malnutrition—Carmustine—lymphatic system cancer	0.00197	0.00576	CcSEcCtD
Bromazepam—Mental disorder—Vincristine—lymphatic system cancer	0.00189	0.00553	CcSEcCtD
Bromazepam—Confusional state—Bleomycin—lymphatic system cancer	0.00186	0.00543	CcSEcCtD
Bromazepam—Vision blurred—Carmustine—lymphatic system cancer	0.00186	0.00543	CcSEcCtD
Bromazepam—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00185	0.00541	CcSEcCtD
Bromazepam—Tremor—Carmustine—lymphatic system cancer	0.00184	0.0054	CcSEcCtD
Bromazepam—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00184	0.00538	CcSEcCtD
Bromazepam—Vomiting—Teniposide—lymphatic system cancer	0.00182	0.00531	CcSEcCtD
Bromazepam—Agitation—Carmustine—lymphatic system cancer	0.00181	0.00529	CcSEcCtD
Bromazepam—Asthenia—Fludarabine—lymphatic system cancer	0.0018	0.00527	CcSEcCtD
Bromazepam—Rash—Teniposide—lymphatic system cancer	0.0018	0.00527	CcSEcCtD
Bromazepam—Dermatitis—Teniposide—lymphatic system cancer	0.0018	0.00526	CcSEcCtD
Bromazepam—Headache—Teniposide—lymphatic system cancer	0.00179	0.00523	CcSEcCtD
Bromazepam—Pruritus—Fludarabine—lymphatic system cancer	0.00178	0.0052	CcSEcCtD
Bromazepam—Anorexia—Bleomycin—lymphatic system cancer	0.00176	0.00513	CcSEcCtD
Bromazepam—Agitation—Vincristine—lymphatic system cancer	0.00173	0.00505	CcSEcCtD
Bromazepam—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00173	0.00505	CcSEcCtD
Bromazepam—Hypotension—Bleomycin—lymphatic system cancer	0.00172	0.00503	CcSEcCtD
Bromazepam—Convulsion—Carmustine—lymphatic system cancer	0.00171	0.00499	CcSEcCtD
Bromazepam—Nausea—Teniposide—lymphatic system cancer	0.0017	0.00496	CcSEcCtD
Bromazepam—Convulsion—Vincristine—lymphatic system cancer	0.00163	0.00476	CcSEcCtD
Bromazepam—Confusional state—Carmustine—lymphatic system cancer	0.00162	0.00474	CcSEcCtD
Bromazepam—Decreased appetite—Bleomycin—lymphatic system cancer	0.0016	0.00468	CcSEcCtD
Bromazepam—Vomiting—Fludarabine—lymphatic system cancer	0.0016	0.00467	CcSEcCtD
Bromazepam—Convulsion—Mitoxantrone—lymphatic system cancer	0.00159	0.00464	CcSEcCtD
Bromazepam—Rash—Fludarabine—lymphatic system cancer	0.00158	0.00463	CcSEcCtD
Bromazepam—Dermatitis—Fludarabine—lymphatic system cancer	0.00158	0.00463	CcSEcCtD
Bromazepam—Headache—Fludarabine—lymphatic system cancer	0.00157	0.0046	CcSEcCtD
Bromazepam—Tachycardia—Carmustine—lymphatic system cancer	0.00157	0.00459	CcSEcCtD
Bromazepam—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00153	0.00449	CcSEcCtD
Bromazepam—Anorexia—Carmustine—lymphatic system cancer	0.00153	0.00448	CcSEcCtD
Bromazepam—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00152	0.00444	CcSEcCtD
Bromazepam—Confusional state—Mitoxantrone—lymphatic system cancer	0.00151	0.00441	CcSEcCtD
Bromazepam—Nervous system disorder—Vincristine—lymphatic system cancer	0.0015	0.0044	CcSEcCtD
Bromazepam—Hypotension—Carmustine—lymphatic system cancer	0.0015	0.00439	CcSEcCtD
Bromazepam—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00149	0.00437	CcSEcCtD
Bromazepam—Nausea—Fludarabine—lymphatic system cancer	0.00149	0.00436	CcSEcCtD
Bromazepam—Anorexia—Vincristine—lymphatic system cancer	0.00146	0.00428	CcSEcCtD
Bromazepam—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00146	0.00426	CcSEcCtD
Bromazepam—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00145	0.00424	CcSEcCtD
Bromazepam—Irritability—Methotrexate—lymphatic system cancer	0.00145	0.00423	CcSEcCtD
Bromazepam—Hypotension—Vincristine—lymphatic system cancer	0.00143	0.00419	CcSEcCtD
Bromazepam—Somnolence—Carmustine—lymphatic system cancer	0.00143	0.00418	CcSEcCtD
Bromazepam—Anorexia—Mitoxantrone—lymphatic system cancer	0.00142	0.00416	CcSEcCtD
Bromazepam—Ataxia—Methotrexate—lymphatic system cancer	0.00142	0.00416	CcSEcCtD
Bromazepam—Decreased appetite—Carmustine—lymphatic system cancer	0.0014	0.00409	CcSEcCtD
Bromazepam—Hypotension—Mitoxantrone—lymphatic system cancer	0.0014	0.00408	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00139	0.00406	CcSEcCtD
Bromazepam—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00136	0.00397	CcSEcCtD
Bromazepam—Decreased appetite—Vincristine—lymphatic system cancer	0.00133	0.0039	CcSEcCtD
Bromazepam—Somnolence—Mitoxantrone—lymphatic system cancer	0.00133	0.00388	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00132	0.00387	CcSEcCtD
Bromazepam—Feeling abnormal—Carmustine—lymphatic system cancer	0.00132	0.00387	CcSEcCtD
Bromazepam—Fatigue—Vincristine—lymphatic system cancer	0.00132	0.00387	CcSEcCtD
Bromazepam—Asthenia—Bleomycin—lymphatic system cancer	0.00132	0.00386	CcSEcCtD
Bromazepam—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00132	0.00385	CcSEcCtD
Bromazepam—Pruritus—Bleomycin—lymphatic system cancer	0.0013	0.00381	CcSEcCtD
Bromazepam—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.0013	0.0038	CcSEcCtD
Bromazepam—Fatigue—Mitoxantrone—lymphatic system cancer	0.00129	0.00377	CcSEcCtD
Bromazepam—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00123	0.0036	CcSEcCtD
Bromazepam—Hypersensitivity—Carmustine—lymphatic system cancer	0.00118	0.00346	CcSEcCtD
Bromazepam—Vomiting—Bleomycin—lymphatic system cancer	0.00117	0.00342	CcSEcCtD
Bromazepam—Drowsiness—Methotrexate—lymphatic system cancer	0.00117	0.00341	CcSEcCtD
Bromazepam—Rash—Bleomycin—lymphatic system cancer	0.00116	0.00339	CcSEcCtD
Bromazepam—Dermatitis—Bleomycin—lymphatic system cancer	0.00116	0.00339	CcSEcCtD
Bromazepam—Asthenia—Carmustine—lymphatic system cancer	0.00115	0.00337	CcSEcCtD
Bromazepam—Hypersensitivity—Vincristine—lymphatic system cancer	0.00113	0.00331	CcSEcCtD
Bromazepam—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.0011	0.00322	CcSEcCtD
Bromazepam—Asthenia—Vincristine—lymphatic system cancer	0.0011	0.00322	CcSEcCtD
Bromazepam—Nausea—Bleomycin—lymphatic system cancer	0.00109	0.0032	CcSEcCtD
Bromazepam—Asthenia—Mitoxantrone—lymphatic system cancer	0.00107	0.00313	CcSEcCtD
Bromazepam—Dizziness—Carmustine—lymphatic system cancer	0.00106	0.00311	CcSEcCtD
Bromazepam—Vomiting—Carmustine—lymphatic system cancer	0.00102	0.00299	CcSEcCtD
Bromazepam—Dizziness—Vincristine—lymphatic system cancer	0.00101	0.00297	CcSEcCtD
Bromazepam—Rash—Carmustine—lymphatic system cancer	0.00101	0.00296	CcSEcCtD
Bromazepam—Dermatitis—Carmustine—lymphatic system cancer	0.00101	0.00296	CcSEcCtD
Bromazepam—Headache—Carmustine—lymphatic system cancer	0.00101	0.00294	CcSEcCtD
Bromazepam—Eye disorder—Methotrexate—lymphatic system cancer	0.000979	0.00286	CcSEcCtD
Bromazepam—Vomiting—Vincristine—lymphatic system cancer	0.000975	0.00285	CcSEcCtD
Bromazepam—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000972	0.00284	CcSEcCtD
Bromazepam—Rash—Vincristine—lymphatic system cancer	0.000967	0.00283	CcSEcCtD
Bromazepam—Dermatitis—Vincristine—lymphatic system cancer	0.000966	0.00283	CcSEcCtD
Bromazepam—Headache—Vincristine—lymphatic system cancer	0.000961	0.00281	CcSEcCtD
Bromazepam—Nausea—Carmustine—lymphatic system cancer	0.000955	0.00279	CcSEcCtD
Bromazepam—Vomiting—Mitoxantrone—lymphatic system cancer	0.00095	0.00278	CcSEcCtD
Bromazepam—Rash—Mitoxantrone—lymphatic system cancer	0.000942	0.00275	CcSEcCtD
Bromazepam—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000941	0.00275	CcSEcCtD
Bromazepam—Headache—Mitoxantrone—lymphatic system cancer	0.000936	0.00274	CcSEcCtD
Bromazepam—Mental disorder—Methotrexate—lymphatic system cancer	0.000918	0.00268	CcSEcCtD
Bromazepam—Malnutrition—Methotrexate—lymphatic system cancer	0.000912	0.00267	CcSEcCtD
Bromazepam—Nausea—Vincristine—lymphatic system cancer	0.000911	0.00266	CcSEcCtD
Bromazepam—Nausea—Mitoxantrone—lymphatic system cancer	0.000887	0.0026	CcSEcCtD
Bromazepam—Vision blurred—Methotrexate—lymphatic system cancer	0.00086	0.00251	CcSEcCtD
Bromazepam—Convulsion—Methotrexate—lymphatic system cancer	0.00079	0.00231	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000771	0.00226	CcSEcCtD
Bromazepam—Confusional state—Methotrexate—lymphatic system cancer	0.000751	0.0022	CcSEcCtD
Bromazepam—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000744	0.00218	CcSEcCtD
Bromazepam—Nervous system disorder—Methotrexate—lymphatic system cancer	0.00073	0.00213	CcSEcCtD
Bromazepam—Skin disorder—Methotrexate—lymphatic system cancer	0.000723	0.00211	CcSEcCtD
Bromazepam—Anorexia—Methotrexate—lymphatic system cancer	0.00071	0.00208	CcSEcCtD
Bromazepam—Hypotension—Methotrexate—lymphatic system cancer	0.000696	0.00203	CcSEcCtD
Bromazepam—Somnolence—Methotrexate—lymphatic system cancer	0.000662	0.00194	CcSEcCtD
Bromazepam—Dyspepsia—Methotrexate—lymphatic system cancer	0.000655	0.00192	CcSEcCtD
Bromazepam—Decreased appetite—Methotrexate—lymphatic system cancer	0.000647	0.00189	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000643	0.00188	CcSEcCtD
Bromazepam—Fatigue—Methotrexate—lymphatic system cancer	0.000642	0.00188	CcSEcCtD
Bromazepam—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000613	0.00179	CcSEcCtD
Bromazepam—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000548	0.0016	CcSEcCtD
Bromazepam—Asthenia—Methotrexate—lymphatic system cancer	0.000534	0.00156	CcSEcCtD
Bromazepam—Pruritus—Methotrexate—lymphatic system cancer	0.000527	0.00154	CcSEcCtD
Bromazepam—Dizziness—Methotrexate—lymphatic system cancer	0.000492	0.00144	CcSEcCtD
Bromazepam—Vomiting—Methotrexate—lymphatic system cancer	0.000473	0.00138	CcSEcCtD
Bromazepam—Rash—Methotrexate—lymphatic system cancer	0.000469	0.00137	CcSEcCtD
Bromazepam—Dermatitis—Methotrexate—lymphatic system cancer	0.000469	0.00137	CcSEcCtD
Bromazepam—Headache—Methotrexate—lymphatic system cancer	0.000466	0.00136	CcSEcCtD
Bromazepam—Nausea—Methotrexate—lymphatic system cancer	0.000442	0.00129	CcSEcCtD
